Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Peringkat dalam Saham #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Harga Saham
$0.02765
Terakhir disinkronkan: 2024-12-23
Kapitalisasi Pasar
$69.04K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Histogen Inc. (HSTO)

Kategori

Jumlah saham beredar untuk Histogen Inc. (HSTO)
Jumlah saham beredar per September 2023: 4.27M
Menurut laporan keuangan terbaru dan harga saham Histogen Inc., jumlah saham beredar saat ini adalah 4.27M. Pada akhir December 2021, perusahaan memiliki 1.92M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Histogen Inc. (HSTO) dari 2011 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 4.27M 33.04%
2022 3.21M 67.41%
2021 1.92M 325.35%
2020 450.92K -23.66%
2019 590.69K 289.00%
2018 151.85K 6.24%
2017 142.93K 26.21%
2016 113.25K -99.39%
2015 18.62M 20.28%
2014 15.48M 110.37%
2013 7.36M 15,800.25%
2012 46.28K 0.00%
2011 46.28K 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
253.90M 5,843.35%
US
62.19M 1,355.65%
NL
- -
CH
- -
KR
0.00 -100.00%
BE